271 related articles for article (PubMed ID: 33925474)
1. 8p23.2-pter Microdeletions: Seven New Cases Narrowing the Candidate Region and Review of the Literature.
Catusi I; Garzo M; Capra AP; Briuglia S; Baldo C; Canevini MP; Cantone R; Elia F; Forzano F; Galesi O; Grosso E; Malacarne M; Peron A; Romano C; Saccani M; Larizza L; Recalcati MP
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33925474
[TBL] [Abstract][Full Text] [Related]
2. Isolated chromosome 8p23.2‑pter deletion: Novel evidence for developmental delay, intellectual disability, microcephaly and neurobehavioral disorders.
Shi S; Lin S; Chen B; Zhou Y
Mol Med Rep; 2017 Nov; 16(5):6837-6845. PubMed ID: 28901431
[TBL] [Abstract][Full Text] [Related]
3. 8p23.1 Interstitial Deletion in a Patient with Congenital Cardiopathy, Neurobehavioral Disorders, and Minor Signs Suggesting 22q11.2 Deletion Syndrome.
Molck MC; Monteiro FP; Simioni M; Gil-da-Silva-Lopes VL
J Dev Behav Pediatr; 2015 Sep; 36(7):544-8. PubMed ID: 26263419
[TBL] [Abstract][Full Text] [Related]
4. Two patients with atypical interstitial deletions of 8p23.1: mapping of phenotypical traits.
Páez MT; Yamamoto T; Hayashi K; Yasuda T; Harada N; Matsumoto N; Kurosawa K; Furutani Y; Asakawa S; Shimizu N; Matsuoka R
Am J Med Genet A; 2008 May; 146A(9):1158-65. PubMed ID: 18393291
[TBL] [Abstract][Full Text] [Related]
5. A new microdeletion syndrome involving TBC1D24, ATP6V0C, and PDPK1 causes epilepsy, microcephaly, and developmental delay.
Mucha BE; Banka S; Ajeawung NF; Molidperee S; Chen GG; Koenig MK; Adejumo RB; Till M; Harbord M; Perrier R; Lemyre E; Boucher RM; Skotko BG; Waxler JL; Thomas MA; Hodge JC; Gecz J; Nicholl J; McGregor L; Linden T; Sisodiya SM; Sanlaville D; Cheung SW; Ernst C; Campeau PM
Genet Med; 2019 May; 21(5):1058-1064. PubMed ID: 30245510
[TBL] [Abstract][Full Text] [Related]
6. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
[TBL] [Abstract][Full Text] [Related]
7. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44.
Ballif BC; Rosenfeld JA; Traylor R; Theisen A; Bader PI; Ladda RL; Sell SL; Steinraths M; Surti U; McGuire M; Williams S; Farrell SA; Filiano J; Schnur RE; Coffey LB; Tervo RC; Stroud T; Marble M; Netzloff M; Hanson K; Aylsworth AS; Bamforth JS; Babu D; Niyazov DM; Ravnan JB; Schultz RA; Lamb AN; Torchia BS; Bejjani BA; Shaffer LG
Hum Genet; 2012 Jan; 131(1):145-56. PubMed ID: 21800092
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterization of an emerging chromosome 22q13.31 microdeletion syndrome.
Palumbo P; Accadia M; Leone MP; Palladino T; Stallone R; Carella M; Palumbo O
Am J Med Genet A; 2018 Feb; 176(2):391-398. PubMed ID: 29193617
[TBL] [Abstract][Full Text] [Related]
9. A novel microdeletion syndrome at 9q21.13 characterised by mental retardation, speech delay, epilepsy and characteristic facial features.
Boudry-Labis E; Demeer B; Le Caignec C; Isidor B; Mathieu-Dramard M; Plessis G; George AM; Taylor J; Aftimos S; Wiemer-Kruel A; Kohlhase J; Annerén G; Firth H; Simonic I; Vermeesch J; Thuresson AC; Copin H; Love DR; Andrieux J
Eur J Med Genet; 2013 Mar; 56(3):163-70. PubMed ID: 23279911
[TBL] [Abstract][Full Text] [Related]
10. The rare 13q33-q34 microdeletions: eight new patients and review of the literature.
Sagi-Dain L; Goldberg Y; Peleg A; Sukenik-Halevy R; Sofrin-Drucker E; Appelman Z; Josefsberg BYS; Ben-Shachar S; Vinkler C; Basel-Salmon L; Maya I
Hum Genet; 2019 Oct; 138(10):1145-1153. PubMed ID: 31321490
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
12. Refining critical regions in 15q24 microdeletion syndrome pertaining to autism.
Liu Y; Zhang Y; Zarrei M; Dong R; Yang X; Zhao D; Scherer SW; Gai Z
Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):217-226. PubMed ID: 31953991
[TBL] [Abstract][Full Text] [Related]
13. Clinical characterization of individuals with the distal 1q21.1 microdeletion.
Edwards SD; Schulze KV; Rosenfeld JA; Westerfield LE; Gerard A; Yuan B; Grigorenko EL; Posey JE; Bi W; Liu P
Am J Med Genet A; 2021 May; 185(5):1388-1398. PubMed ID: 33576134
[TBL] [Abstract][Full Text] [Related]
14. Inside the 8p23.1 duplication syndrome; eight microduplications of likely or uncertain clinical significance.
Barber JC; Rosenfeld JA; Graham JM; Kramer N; Lachlan KL; Bateman MS; Collinson MN; Stadheim BF; Turner CL; Gauthier JN; Reimschisel TE; Qureshi AM; Dabir TA; Humphreys MW; Marble M; Huang T; Beal SJ; Massiah J; Taylor EJ; Wynn SL
Am J Med Genet A; 2015 Sep; 167A(9):2052-64. PubMed ID: 26097203
[TBL] [Abstract][Full Text] [Related]
15. De novo 8p23.1 deletion in a patient with absence epilepsy.
Akcakaya NH; Capan ÖY; Schulz H; Sander T; Caglayan SH; Yapıcı Z
Epileptic Disord; 2017 Jun; 19(2):217-221. PubMed ID: 28533195
[TBL] [Abstract][Full Text] [Related]
16. Five patients with novel overlapping interstitial deletions in 8q22.2q22.3.
Kuechler A; Buysse K; Clayton-Smith J; Le Caignec C; David A; Engels H; Kohlhase J; Mari F; Mortier G; Renieri A; Wieczorek D
Am J Med Genet A; 2011 Aug; 155A(8):1857-64. PubMed ID: 21739578
[TBL] [Abstract][Full Text] [Related]
17. A recognizable phenotype related to 19p13.12 microdeletion.
de Souza LC; Sgardioli IC; Gil-da-Silva-Lopes VL; Vieira TP
Am J Med Genet A; 2018 Aug; 176(8):1753-1759. PubMed ID: 30055032
[TBL] [Abstract][Full Text] [Related]
18. Intragenic Deletion of the ZMYND11 Gene in 10p15.3 is Associated with Developmental Delay Phenotype: A Case Report.
Huynh MT; Tran CT; Joubert M; Bénéteau C
Cytogenet Genome Res; 2021; 161(8-9):445-448. PubMed ID: 34818214
[TBL] [Abstract][Full Text] [Related]
19. Familial 18q12.2 deletion supports the role of RNA-binding protein CELF4 in autism spectrum disorders.
Barone R; Fichera M; De Grandi M; Battaglia M; Lo Faro V; Mattina T; Rizzo R
Am J Med Genet A; 2017 Jun; 173(6):1649-1655. PubMed ID: 28407444
[TBL] [Abstract][Full Text] [Related]
20. A genotype-first approach for the molecular and clinical characterization of uncommon de novo microdeletion of 20q13.33.
Traylor RN; Bruno DL; Burgess T; Wildin R; Spencer A; Ganesamoorthy D; Amor DJ; Hunter M; Caplan M; Rosenfeld JA; Theisen A; Torchia BS; Shaffer LG; Ballif BC; Slater HR
PLoS One; 2010 Aug; 5(8):e12462. PubMed ID: 20805988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
